Ryvu Therapeutics SA Cash Flow-to-Debt Ratio
Ryvu Therapeutics SA cash flow-to-debt ratio. Ryvu Therapeutics SA (RVU) has a Cash Flow-to-Debt Ratio of -0.14x as of March 2026, meaning its operating cash flow of zł-22.84 Million could theoretically repay 0% of its total liabilities (zł159.63 Million) in one year. Check Ryvu Therapeutics SA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ryvu Therapeutics SA (2010–2025)
Cash flow-to-debt ratio of Ryvu Therapeutics SA from 2010 to 2025. Historical debt coverage capacity for Ryvu Therapeutics SA across 16 annual periods. Check Ryvu Therapeutics SA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ryvu Therapeutics SA Cash Flow-to-Debt Ratio by Year (2010–2025)
Ryvu Therapeutics SA cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for Ryvu Therapeutics SA. For the full cash flow conversion analysis, see Ryvu Therapeutics SA operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.72x | zł-110.28 Million | zł153.69 Million | ▼ -30.2% |
| 2024 | -0.55x | zł-129.48 Million | zł234.89 Million | ▲ +6.4% |
| 2023 | -0.59x | zł-84.55 Million | zł143.61 Million | ▼ -463.4% |
| 2022 | 0.16x | zł21.32 Million | zł131.59 Million | ▲ +116.6% |
| 2021 | -0.97x | zł-57.87 Million | zł59.39 Million | ▼ -558.8% |
| 2020 | -0.15x | zł-10.64 Million | zł71.92 Million | ▲ +46.3% |
| 2019 | -0.28x | zł-17.40 Million | zł63.13 Million | ▲ +54.0% |
| 2018 | -0.60x | zł-36.42 Million | zł60.84 Million | ▼ -315.7% |
| 2017 | 0.28x | zł10.98 Million | zł39.58 Million | ▲ +247.6% |
| 2016 | -0.19x | zł-6.28 Million | zł33.41 Million | ▲ +79.0% |
| 2015 | -0.89x | zł-16.43 Million | zł18.36 Million | ▼ -220.3% |
| 2014 | -0.28x | zł-4.90 Million | zł17.55 Million | ▲ +99.4% |
| 2013 | -46.80x | zł-694.94 Million | zł14.85 Million | ▼ -5060.4% |
| 2012 | -0.91x | zł-8.90 Million | zł9.82 Million | ▲ +8.4% |
| 2011 | -0.99x | zł-5.98 Million | zł6.04 Million | ▼ -134.1% |
| 2010 | -0.42x | zł-3.71 Million | zł8.77 Million | — |